rs684805

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001378964.1(CDON):​c.3039C>T​(p.Asn1013Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.272 in 1,613,168 control chromosomes in the GnomAD database, including 62,717 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 8310 hom., cov: 32)
Exomes 𝑓: 0.27 ( 54407 hom. )

Consequence

CDON
NM_001378964.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.808

Publications

15 publications found
Variant links:
Genes affected
CDON (HGNC:17104): (cell adhesion associated, oncogene regulated) This gene encodes a cell surface receptor that is a member of the immunoglobulin superfamily. The encoded protein contains three fibronectin type III domains and five immunoglobulin-like C2-type domains. This protein is a member of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells and positively regulates myogenesis. [provided by RefSeq, Aug 2011]
CDON Gene-Disease associations (from GenCC):
  • holoprosencephaly 11
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Illumina
  • pituitary stalk interruption syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 11-125981286-G-A is Benign according to our data. Variant chr11-125981286-G-A is described in ClinVar as Benign. ClinVar VariationId is 260791.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.808 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.454 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDONNM_001378964.1 linkc.3039C>T p.Asn1013Asn synonymous_variant Exon 17 of 20 ENST00000531738.6 NP_001365893.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDONENST00000531738.6 linkc.3039C>T p.Asn1013Asn synonymous_variant Exon 17 of 20 1 NM_001378964.1 ENSP00000432901.2 Q4KMG0-2E9PN78

Frequencies

GnomAD3 genomes
AF:
0.315
AC:
47789
AN:
151794
Hom.:
8286
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.459
Gnomad AMI
AF:
0.457
Gnomad AMR
AF:
0.245
Gnomad ASJ
AF:
0.337
Gnomad EAS
AF:
0.0795
Gnomad SAS
AF:
0.210
Gnomad FIN
AF:
0.290
Gnomad MID
AF:
0.244
Gnomad NFE
AF:
0.271
Gnomad OTH
AF:
0.274
GnomAD2 exomes
AF:
0.256
AC:
64369
AN:
251270
AF XY:
0.252
show subpopulations
Gnomad AFR exome
AF:
0.467
Gnomad AMR exome
AF:
0.204
Gnomad ASJ exome
AF:
0.335
Gnomad EAS exome
AF:
0.0800
Gnomad FIN exome
AF:
0.302
Gnomad NFE exome
AF:
0.266
Gnomad OTH exome
AF:
0.251
GnomAD4 exome
AF:
0.267
AC:
390628
AN:
1461256
Hom.:
54407
Cov.:
36
AF XY:
0.265
AC XY:
192620
AN XY:
726976
show subpopulations
African (AFR)
AF:
0.465
AC:
15574
AN:
33466
American (AMR)
AF:
0.210
AC:
9373
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.334
AC:
8740
AN:
26130
East Asian (EAS)
AF:
0.0795
AC:
3155
AN:
39700
South Asian (SAS)
AF:
0.222
AC:
19170
AN:
86250
European-Finnish (FIN)
AF:
0.299
AC:
15965
AN:
53350
Middle Eastern (MID)
AF:
0.230
AC:
1328
AN:
5768
European-Non Finnish (NFE)
AF:
0.271
AC:
301408
AN:
1111492
Other (OTH)
AF:
0.264
AC:
15915
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
16094
32187
48281
64374
80468
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10142
20284
30426
40568
50710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.315
AC:
47866
AN:
151912
Hom.:
8310
Cov.:
32
AF XY:
0.311
AC XY:
23054
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.459
AC:
19015
AN:
41394
American (AMR)
AF:
0.244
AC:
3731
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.337
AC:
1169
AN:
3466
East Asian (EAS)
AF:
0.0791
AC:
409
AN:
5168
South Asian (SAS)
AF:
0.211
AC:
1015
AN:
4812
European-Finnish (FIN)
AF:
0.290
AC:
3054
AN:
10544
Middle Eastern (MID)
AF:
0.252
AC:
74
AN:
294
European-Non Finnish (NFE)
AF:
0.271
AC:
18402
AN:
67956
Other (OTH)
AF:
0.276
AC:
581
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1590
3179
4769
6358
7948
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
448
896
1344
1792
2240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.272
Hom.:
9115
Bravo
AF:
0.317
Asia WGS
AF:
0.206
AC:
716
AN:
3478
EpiCase
AF:
0.256
EpiControl
AF:
0.255

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly 11 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.12
DANN
Benign
0.52
PhyloP100
-0.81
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs684805; hg19: chr11-125851181; COSMIC: COSV54996083; API